Research Article

Evaluation of Oral Robenacoxib for the Treatment of Postoperative Pain and Inflammation in Cats: Results of a Randomized Clinical Trial

Table 5

Selected serum and urine renal biomarkers measured at study exit.

Variable: unitsRobenacoxib 𝑛 = 1 5 0 Placebo 𝑛 = 7 3 Reference rangeP value
MeanSD# Cases*MeanSD# Cases*
HighLowHighLow

Urea Nitrogen: mg/dL23.214.891122.335.860414–360.48
Creatinine: mg/dL1.070.24011.060.26000.6–2.40.52
BUN : Creatinine Ratio22.747.075021.746.06204–330.87
Total Protein: g/dL7.010.61017.110.63005.2–8.80.60
Albumin: g/dL3.210.32043.150.29022.5–3.90.14

Robenacoxib 𝑛 = 1 3 3 Placebo 𝑛 = 6 5
Variable: unitsMeanSD# Cases*MeanSD# Cases*Reference rangeP value
HighLowHighLow

Urine specific gravity1.0600.013211.0500.021001.015–1.0600.020**

βˆ— Number of cases with values higher (high) or lower (low) than reference range.
βˆ— βˆ— 𝑃 value < 0.05.